ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

KNTE Kinnate Biopharma Inc

2,65
0,00 (0,00%)
Nach Börsenschluss
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Kinnate Biopharma Inc KNTE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 2,65 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,65 2,65
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.4.202415:00GLOBEXOMA Corporation Announces Closing of Tender Offer
19.3.202421:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
05.3.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:27EDGAR2Form SC 14D9 - Solicitation, recommendation statements
01.3.202414:53EDGAR2Form SC14D9C - Written communication relating to third party..
01.3.202414:50EDGAR2Form 8-K - Current report
01.3.202414:35PRNUSKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
01.3.202414:30GLOBEKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
21.2.202412:01EDGAR2Form SC14D9C - Written communication relating to third party..
16.2.202423:57PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
16.2.202416:46PRNUSKuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to..
16.2.202415:10EDGAR2Form 8-K - Current report
16.2.202414:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
14.2.202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16.1.202422:05EDGAR2Form 8-K - Current report
05.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202315:00EDGAR2Form 8-K - Current report
09.11.202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:14EDGAR2Form 8-K - Current report
09.11.202322:05GLOBEKinnate Biopharma Inc. Reports Third Quarter 2023 Financial..
18.9.202322:28EDGAR2Form 8-K - Current report
18.9.202322:10GLOBEKinnate Biopharma Inc. Announces Pipeline Updates, Strategic..
06.9.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202322:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:16EDGAR2Form 8-K - Current report
08.8.202322:05GLOBEKinnate Biopharma Inc. Reports Second Quarter 2023 Financial..
28.7.202322:06EDGAR2Form 8-K - Current report
01.6.202322:05GLOBEKinnate Biopharma Inc. to Participate in Upcoming Investor..
11.5.202322:05GLOBEKinnate Biopharma Inc. Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht